Congenica Appoints Wendy Britten as CFO

A finance professional with experience in senior financial leadership roles, Mrs Britten joins Congenica from AstraZeneca, where she headed up the Group Finance Business Performance team, working with the Senior Executive team. Prior to this, her career at PricewaterhouseCoopers (PwC) started in Audit, progressing ultimately to Director of M&A in both London and New York. She is a qualified Chartered Accountant and holds a BSc in Mathematics from the University of Sheffield.

Commenting on her appointment, Congenica’s new CFO Mrs Wendy Britten said: “I am looking forward to the opportunities that joining the team at Congenica offers. With a strong commitment to positively impacting patient’s lives, Congenica is poised for substantial growth. The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”